Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections

Gut

Volumn 65, Issue 1, 2016, Pages 100-111

  Noel, Pawan ^a   Patel, Krutika ^a   Durgampudi, Chandra ^b   Trivedi, Ram N ^a   De Oliveira, Cristiane ^a   Crowell, Michael D ^a   Pannala, Rahul ^a   Lee, Kenneth ^b   Brand, Randall ^c   Chennat, Jennifer ^c   Slivka, Adam ^c   Papachristou, Georgios I ^c   Khalid, Asif ^c   Whitcomb, David C ^c   DeLany, James P ^c   Cline, Rachel A ^c   Acharya, Chathur ^b   Jaligama, Deepthi ^b   Murad, Faris M ^d   Yadav, Dhiraj ^c   Navina, Sarah ^c   Singh, Vijay P ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; INTERLEUKIN 1BETA; INTERLEUKIN 8; KERATINOCYTE DERIVED CHEMOKINE; LINOLEIC ACID; OLEIC ACID; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TRIOLEIN; UNSATURATED FATTY ACID; BIOLOGICAL MARKER; CYTOKINE; IL1B PROTEIN, RAT;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT NECROSIS; HUMAN; LIPOLYSIS; MULTIPLE ORGAN FAILURE; NONHUMAN; OBESITY; PANCREAS NECROSIS; PANCREAS PSEUDOCYST; PERIPANCREATIC FAT NECROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; ACINAR CELL; ACUTE HEMORRHAGIC PANCREATITIS; ADULT; AGED; ANIMAL; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PANCREAS; PATHOLOGY; SEVERITY OF ILLNESS INDEX; WISTAR RAT;

ACINAR CELLS; ADULT; AGED; ANIMALS; BIOMARKERS; CYTOKINES; FAT NECROSIS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOLYSIS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREAS; PANCREATIC PSEUDOCYST; PANCREATITIS, ACUTE NECROTIZING; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX;

EID: 84955690536     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308043     Document Type: Article

References (129)

1. Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med 2011;3:107ra10.
2. Sennello JA, Fayad R, Pini M, et al. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proc Natl Acad Sci USA 2008;105:8085-90.
3. Schaffler A, Hamer O, Dickopf J, et al. Admission resistin levels predict peripancreatic necrosis and clinical severity in acute pancreatitis. Am J Gastroenterol 2010;105:2474-84.
4. Schaffler A, Hamer OW, Dickopf J, et al. Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severity. Am J Gastroenterol 2011;106:957-67.
5. Geokas MC, Rinderknecht H, Brodrick JW, et al. Studies on the ascites fluid of acute pancreatitis in man. Am J Dig Dis 1978;23:182-8.
6. Buchler M, Malfertheiner P, Uhl W, et al. [Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)]. Med Klin (Munich) 1988;83:320-4, 52.
7. Berling R, Borgstrom A, Ohlsson K. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors. Int J Pancreatol 1998;24:9-17.
8. Renner IG, Rinderknecht H, Douglas AP. Profiles of pure pancreatic secretions in patients with acute pancreatitis: the possible role of proteolytic enzymes in pathogenesis. Gastroenterology 1978;75:1090-8.
9. Domschke S, Malfertheiner P, Uhl W, et al. Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis. Int J Pancreatol 1993;13:105-10.
10. Panek J, Sztefko K, Drozdz W. Composition of free fatty acid and triglyceride fractions in human necrotic pancreatic tissue. Med Sci Monit 2001;7:894-8.
11. Hirota M, Nozawa F, Okabe A, et al. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000;21:141-6.
12. Messmann H, Vogt W, Falk W, et al. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. Eur J Gastroenterol Hepatol 1998;10:611-17.
13. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death.Parisian Study Group on acute pancreatitis. Crit Care Med 1999;27:749-55.
14. Dambrauskas Z, Giese N, Gulbinas A, et al. Different profiles of cytokine expression during mild and severe acute pancreatitis. World J Gastroenterol 2010;16:1845-53.
15. Aoun E, Chen J, Reighard D, et al. Diagnostic accuracy of interleukin-6 and interleukin-8 in predicting severe acute pancreatitis: a meta-analysis. Pancreatology 2009;9:777-85.
16. Daniel P, Lesniowski B, Mokrowiecka A, et al. Circulating levels of visfatin, resistin and pro-inflammatory cytokine interleukin-8 in acute pancreatitis. Pancreatology 2010;10:477-82.
17. Regner S, Appelros S, Hjalmarsson C, et al. Monocyte chemoattractant protein 1, active carboxypeptidase B and CAPAP at hospital admission are predictive markers for severe acute pancreatitis. Pancreatology 2008;8:42-9.
18. Gregoric P, Sijacki A, Stankovic S, et al. SIRS score on admission and initial concentration of IL-6 as severe acute pancreatitis outcome predictors. Hepatogastroenterology 2010;57:349-53.
19. Al Mofleh IA. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol 2008;14:675-84.
20. Papachristou GI, Whitcomb DC. Predictors of severity and necrosis in acute pancreatitis. Gastroenterol Clin North Am 2004;33:871-90.
21. Chen CH, Dai CY, Hou NJ, et al. Etiology, severity and recurrence of acute pancreatitis in southern taiwan. J Formos Med Assoc 2006;105:550-5.
22. Sekimoto M, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:10-24.
23. Xin MJ, Chen H, Luo B, et al. Severe acute pancreatitis in the elderly: etiology and clinical characteristics. World J Gastroenterol 2008;14:2517-21.
24. Vidarsdottir H, Moller PH, Thorarinsdottir H, et al. Acute pancreatitis: a prospective study on incidence, etiology, and outcome. Eur J Gastroenterol Hepatol 2013;25:1068-75.
25. Buch A, Buch J, Carlsen A, et al. Hyperlipidemia and pancreatitis. World J Surg 1980;4:307-14.
26. Dominguez-Munoz JE, Malfertheiner P, Ditschuneit HH, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol 1991;10:261-7.
27. Deng LH, Xue P, Xia Q, et al. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J Gastroenterol 2008;14:4558-61.
28. Lloret Linares C, Pelletier AL, Czernichow S, et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008;37:13-2.
29. Fu CY, Yeh CN, Hsu JT, et al. Timing of mortality in severe acute pancreatitis: experience from 643 patients. World J Gastroenterol 2007;13:1966-9.
30. Carnovale A, Rabitti PG, Manes G, et al. Mortality in acute pancreatitis: is it an early or a late event? Jop 2005;6:438-44.
31. Mutinga M, Rosenbluth A, Tenner SM, et al. Does mortality occur early or late in acute pancreatitis? Int J Pancreatol 2000;28:91-5.
32. Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol 1980;15:411-16.
33. Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis. Gastroenterology 2013;144:1180-93.
34. Andriulli A, Caruso N, Quitadamo M, et al. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. Jop 2003;4:41-8.
35. Andriulli A, Leandro G, Clemente R, et al. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 1998;12:237-45.
36. Asang E. [Changes in the therapy of inflammatory diseases of the pancreas. A report on 1 year of therapy and prophylaxis with the kallikrein- and trypsin inactivator trasylol (Bayer)]. Langenbecks Arch Klin Chir Ver Dtsch Z Chir 1960;293:645-70.
37. Buchler M, Malfertheiner P, Uhl W, et al. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology 1993;104:1165-70.
38. Chen HM, Chen JC, Hwang TL, et al. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 2000;47:1147-50.
39. Park KT, Kang DH, Choi CW, et al. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 2011;40:1215-19.
40. Seta T, Noguchi Y, Shimada T, et al. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004;16:1287-93.
41. Trapnell JE, Rigby CC, Talbot CH, et al. Proceedings: Aprotinin in the treatment of acute pancreatitis. Gut 1973;14:828.
42. Trapnell JE, Rigby CC, Talbot CH, et al. A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg 1974;61:177-82.
43. Trapnell JE, Talbot CH, Capper WM. Trasylol in acute pancreatitis. Am J Dig Dis 1967;12:409-12.
44. Abbasinazari M, Mohammad Alizadeh AH, Moshiri K, et al. Does allopurinol prevent post endoscopic retrograde cholangio- pancreatography pancreatitis? A randomized double blind trial. Acta Med Iran 2011;49:579-83.
45. Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001;48:62-9.
46. Maser EA, Deconda D, Lichtiger S, et al. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol 2008;6:1112-16.
47. Zeitz J, Huber M, Rogler G. [Serious course of a miliary tuberculosis in a 34-year-old patient with ulcerative colitis and HIV infection under concomitant therapy with infliximab]. Med Klin (Munich) 2010;105:314-18.
48. Jimenez-Fernandez SG, Tremoulet AH. Infliximab treatment of pancreatitis complicating acute kawasaki disease. Pediatr Infect Dis J 2012;31:1087-9.
49. Triantafillidis JK, Cheracakis P, Hereti IA, et al. Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment. Am J Gastroenterol 2000;95:3334-6.
50. Fefferman DS, Alsahli M, Lodhavia PJ, Re: Triantafillidis et al. - Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment. Am J Gastroenterol 2001;96:2510-11.
51. Rebours V, Boutron-Ruault MC, Jooste V, et al. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses. Am J Gastroenterol 2009;104:2312-17.
52. Wang LZ, Su JY, Lu CY, et al. Effects of recombinant human endothelial-derived interleukin-8 on hemorrhagic shock in rats. Zhongguo Yao Li Xue Bao 1997;18:434-6.
53. Morimoto K, Morimoto A, Nakamori T, et al. Cardiovascular responses induced in free-moving rats by immune cytokines. J Physiol 1992;448:307-20.
54. Wogensen L, Jensen M, Svensson P, et al. Pancreatic beta-cell function and interleukin-1 beta in plasma during the acute phase response in patients with major burn injuries. Eur J Clin Invest 1993;23:311-19.
55. Li S, Ballou LR, Morham SG, et al. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res 2001;910:163-73.
56. Bhargava R, Janssen W, Altmann C, et al. Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice. PLoS ONE 2013;8:e61405.
57. Cuzzocrea S, Mazzon E, Dugo L, et al. Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice. Cytokine 2002;18:274-85.
58. Guice KS, Oldham KT, Remick DG, et al. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res 1991;51:495-9.
59. Abu Hilal M, Armstrong T. The impact of obesity on the course and outcome of acute pancreatitis. Obes Surg 2008;18:326-8.
60. Papachristou GI, Papachristou DJ, Avula H, et al. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology 2006;6:279-85.
61. Porter KA, Banks PA. Obesity as a predictor of severity in acute pancreatitis. Int J Pancreatol 1991;10:247-52.
62. Shin KY, Lee WS, Chung DW, et al. Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver 2011;5:335-9.
63. O'Leary DP, O'Neill D, McLaughlin P, et al. Effects of abdominal fat distribution parameters on severity of acute pancreatitis. World J Surg 2012;36:1679-85.
64. Sempere L, Martinez J, de Madaria E, et al. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology 2008;8:257-64.
65. Evans AC, Papachristou GI, Whitcomb DC. Obesity and the risk of severe acute pancreatitis. Minerva Gastroenterol Dietol 2010;56:169-79.
66. Chen SM, Xiong GS, Wu SM. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J Dig Dis 2012;13:244-51.
67. Sadr-Azodi O, Orsini N, Andren-Sandberg A, et al. Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study. Am J Gastroenterol 2013;108:133-9.
68. Yashima Y, Isayama H, Tsujino T, et al. A large volume of visceral adipose tissue leads to severe acute pancreatitis. J Gastroenterol 2011;46:1213-18.
69. Funnell IC, Bornman PC, Weakley SP, et al. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 1993;80:484-6.
70. Hotchkiss LW VIII. Acute pancreatitis with very extensive fat necrosis. Ann Surg 1912;56:111-17.
71. Freeman ML, Werner J, van Santvoort HC, et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas 2012;41:1176-94.
72. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102-11.
73. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-6.
74. Bollen TL, Singh VK, Maurer R, et al. A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol 2012;107:612-19.
75. Singh VK, Bollen TL, Wu BU, et al. An assessment of the severity of interstitial pancreatitis. Clin Gastroenterol Hepatol 2011;9:1098-103.
76. Ren J, Dimitrov I, Sherry AD, et al. Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. J Lipid Res 2008;49:2055-62.
77. Thomas LW. The chemical composition of adipose tissue of man and mice. Q J Exp Physiol Cogn Med Sci 1962;47:179-88.
78. Garaulet M, Hernandez-Morante JJ, Lujan J, et al. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes (Lond) 2006;30:899-905.
79. Cosen-Binker LI, Binker MG, Wang CC, et al. VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. J Clin Invest 2008;118:2535-51.
80. Fallon MB, Gorelick FS, Anderson JM, et al. Effect of cerulein hyperstimulation on the paracellular barrier of rat exocrine pancreas. Gastroenterology 1995;108:1863-72.
81. Gaisano HY, Lutz MP, Leser J, et al. Supramaximal cholecystokinin displaces Munc18c from the pancreatic acinar basal surface, redirecting apical exocytosis to the basal membrane. J Clin Invest 2001;108:1597-611.
82. Lam PP, Cosen Binker LI, Lugea A, et al. Alcohol redirects CCK-mediated apical exocytosis to the acinar basolateral membrane in alcoholic pancreatitis. Traffic 2007;8:605-17.
83. Aho HJ, Sternby B, Kallajoki M, et al. Carboxyl ester lipase in human tissues and in acute pancreatitis. Int J Pancreatol 1989;5:123-34.
84. Kloppel G, Dreyer T, Willemer S, et al. Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch A Pathol Anat Histopathol 1986;409:791-803.
85. Mossner J, Bodeker H, Kimura W, et al. Isolated rat pancreatic acini as a model to study the potential role of lipase in the pathogenesis of acinar cell destruction. Int J Pancreatol 1992;12:285-96.
86. Kimura W, Meyer F, Hess D, et al. Comparison of different treatment modalities in experimental pancreatitis in rats. Gastroenterology 1992;103:1916-24.
87. Machado RM, Nakandakare ER, Quintao EC, et al. Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to trans fatty acids. Atherosclerosis 2012;224:66-74.
88. Alam I, Lewis K, Stephens JW, et al. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev 2007;8:119-27.
89. Wentworth JM, Naselli G, Brown WA, et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010;59:1648-56.
90. Durgampudi C, Noel P, Patel K, et al. Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation. Am J Pathol 2014;184:1773-84.
91. Lowe ME. The triglyceride lipases of the pancreas. J Lipid Res 2002;43:2007-16.
92. Miller R, Lowe ME. Carboxyl ester lipase from either mother's milk or the pancreas is required for efficient dietary triglyceride digestion in suckling mice.J Nutr 2008;138:927-30.
93. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-400.
94. Tenner S, Baillie J, Dewitt J, et al. American college of gastroenterology guidelines: management of acute pancreatitis. Am J Gastroenterol 2013;108:1400-15; 1416.
95. Singh VP, Saluja AK, Bhagat L, et al. Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J Clin Invest 2001;108:1387-95.
96. Singh VP, Saluja AK, Bhagat L, et al. Serine protease inhibitor causes F-actin redistribution and inhibition of calcium-mediated secretion in pancreatic acini. Gastroenterology 2001;120:1818-27.
97. Singh VP, McNiven MA.Src-mediated cortactin phosphorylation regulates actin localization and injurious blebbing in acinar cells. Mol Biol Cell 2008;19:2339-47.
98. Bhagat L, Singh VP, Song AM, et al. Thermal stress-induced HSP70 mediates protection against intrapancreatic trypsinogen activation and acute pancreatitis in rats. Gastroenterology 2002;122:156-5.
99. Leja-Szpak A, Jaworek J, Tomaszewska R, et al. Melatonin precursor; L-tryptophan protects the pancreas from development of acute pancreatitis through the central site of action. J Physiol Pharmacol 2004;55:239-54.
100. Wisner J, Green D, Ferrell L, et al. Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut 1988;29:1516-23.
101. Frevert CW, Huang S, Danaee H, et al. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol 1995;154:335-44.
102. Coelho MM, Luheshi G, Hopkins SJ, et al. Multiple mechanisms mediate antipyretic action of glucocorticoids. Am J Physiol 1995;269:R527-35.
103. Strijbos PJ, Hardwick AJ, Relton JK, et al. Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am J Physiol 1992;263:E632-6.
104. Acharya C, Cline RA, Jaligama D, et al. Fibrosis Reduces Severity of Acute-on-Chronic Pancreatitis in Humans. Gastroenterology 2013;145:466-75.
105. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011;478:103-9.
106. Choh AC, Demerath EW, Lee M, et al. Genetic analysis of self-reported physical activity and adiposity: the Southwest Ohio Family Study. Public Health Nutr 2009;12:1052-60.
107. Demerath EW, Reed D, Choh AC, et al. Rapid postnatal weight gain and visceral adiposity in adulthood: the Fels Longitudinal Study. Obesity (Silver Spring) 2009;17:2060-6.
108. Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007;132:2022-44.
109. Hussain N, Wu F, Zhu L, et al. Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am J Respir Cell Mol Biol 1998;19:867-74.
110. Wu RP, Liang XB, Guo H, et al. Protective effect of low potassium dextran solution on acute kidney injury following acute lung injury induced by oleic acid in piglets. Chin Med J (Engl) 2012;125:3093-7.
111. Inoue H, Nakagawa Y, Ikemura M, et al. Molecular-biological analysis of acute lung injury (ALI) induced by heat exposure and/or intravenous administration of oleic acid. Leg Med (Tokyo) 2012;14:304-8.
112. Lai JP, Bao S, Davis IC, et al. Inhibition of the phosphatase PTEN protects mice against oleic acid-induced acute lung injury. Br J Pharmacol 2009;156:189-200.
113. Bakker OJ, van Santvoort H, Besselink MG, et al. Extrapancreatic necrosis without pancreatic parenchymal necrosis: a separate entity in necrotising pancreatitis? Gut 2013;62:1475-80.
114. Mareninova OA, Sung KF, Hong P, et al. Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 2006;281:3370-81.
115. Voronina SG, Barrow SL, Simpson AW, et al. Dynamic changes in cytosolic and mitochondrial ATP levels in pancreatic acinar cells. Gastroenterology 2010;138:1976-87.
116. Samad A, James A, Wong J, et al. Insulin protects pancreatic acinar cells from palmitoleic acid-induced cellular injury. J Biol Chem 2014;289:23582-95.
117. Sztefko K, Panek J. Serum free fatty acid concentration in patients with acute pancreatitis. Pancreatology 2001;1:230-6.
118. Lazaro EJ, Bose AK, Spraggins R, et al. Lipid alterations in acute pancreatitis. Can J Surg 1978;21:270-1.
119. Moran JH, Nowak G, Grant DF. Analysis of the toxic effects of linoleic acid, 12, 13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria. Toxicol Appl Pharmacol 2001;172:150-61.
120. Ishola DA Jr, Post JA, van Timmeren MM, et al. Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 2006;70:724-31.
121. Dettelbach MA, Deftos LJ, Stewart AF. Intraperitoneal free fatty acids induce severe hypocalcemia in rats: a model for the hypocalcemia of pancreatitis. J Bone Miner Res 1990;5:1249-55.
122. Scherer J, Singh VP, Pitchumoni CS, et al. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol 2014;48:195-203.
123. Ueda T, Takeyama Y, Yasuda T, et al. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J Gastroenterol 2006;41:158-65.
124. Kosaka K, Suzuki K, Hayakawa M, et al. Leukotoxin, a linoleate epoxide: its implication in the late death of patients with extensive burns. Mol Cell Biochem 1994;139:141-8.
125. Zhao F, Wang W, Fang Y, et al. Molecular mechanism of sustained inflation in acute respiratory distress syndrome. J Trauma Acute Care Surg 2012;73:1106-13.
126. Pini M, Rhodes DH, Castellanos KJ, et al. Role of IL-6 in the resolution of pancreatitis in obese mice. J Leukoc Biol 2012;91:957-66.
127. Tsai WC, Strieter RM, Wilkowski JM, et al. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 1998;161:2435-40.
128. Mehrad B, Wiekowski M, Morrison BE, et al. Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am J Respir Crit Care Med 2002;166:1263-8.
129. Batra S, Cai S, Balamayooran G, et al. Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice. J Immunol 2012;188:3458-68.